1/27/12 Contest Update
The Roche bid for Illumina lit a fire under biotechs and Amgen’s munch of Micromet further pumped the 10 Contest portfolios holding MITI. At Friday’s close, the NBI was up 10.94% YTD (vs. up 8.32% YTD a week ago) and the Contest median was up 12.78% YTD (vs. up 7.99% YTD a week ago). The Nasdaq Composite Index was up 8.11% YTD (vs. up 6.97% YTD a week ago).
Another terrific week for PGO’s portfolio, which now leads the Contest with an astounding 30.61% YTD gain for just a single month. Not too shabby are the gains of second place BRAD’s portfolio, up 23.34% YTD, and third place DOUGH’s portfolio, up 21.82% YTD.
At Friday's close, 37 of the 38 Contest portfolios were in the black with 22 of the 38 beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: None
Have a wonderful weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
1/27/12
Rank Name Profit/Loss
1 PGO 30,609
2 BRAD 23,337
3 DOUGH 21,815
4 MOPGCW 19,817
5 RRGE 19,581
6 BULBA 18,938
7 BIOFISH 18,423
8 GENE 18,205
9 SCARAM 17,339
10 JIBACOA 16,367
Week's Top 5 Gainers
Symbol 1/20 1/27 % change
ILMN 36.30 51.69 42.38%
INO 0.43 0.60 39.26%
MITI 8.20 10.90 32.93%
BLRX 3.10 3.96 27.74%
KOOL 0.81 1.02 25.93%
Week's Top 5 Losers
Symbol 1/20 1/27 % change
MNTA 18.91 15.19 -19.67%
NVIV.OB 2.38 2.09 -12.18%
CELGZ 1.90 1.67 -12.11%
TKMR 2.66 2.35 -11.66%
THLD 1.53 1.36 -11.11% |
